reports
- GlobalData Healthcare Department
Capstone Therapeutics Corp (CAPS) - Financial Analysis Review
Capstone Therapeutics Corp (CAPS) - Financial Analysis Review Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone’s AZX100 is used for the prevention of hypertrophic and keloid scarring and treatment of pulmonary and peridural fibrosis. The compan...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.